Sumitomo Chemical Limite... (SOMMY)
OTC: SOMMY
· Real-Time Price · USD
16.43
0.26 (1.61%)
At close: Oct 03, 2025, 3:27 PM
16.17
-1.55%
After-hours: Oct 01, 2025, 08:00 PM EDT
Sumitomo Chemical Income Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 526.14B | 701.45B | 663.44B | 629.25B | 612.14B | 640.02B | 619.99B | 623.73B | 563.14B | 638.24B | 728.48B | 754.43B | 774.13B | 727.44B | 712.67B | 686.23B | 638.98B | 644.37B | 595.84B | 546.58B | 500.19B |
Cost of Revenue | 362.44B | 513.75B | 475.83B | 450.91B | 440.31B | 553.45B | 463.16B | 496.57B | 434.01B | 505.66B | 517.27B | 523.09B | 528.35B | 525.91B | 491.72B | 444.95B | 428.88B | 437.8B | 394.76B | 361.59B | 321.63B |
Gross Profit | 163.7B | 187.69B | 187.6B | 178.34B | 171.84B | 86.57B | 156.84B | 127.16B | 129.13B | 132.58B | 211.21B | 231.34B | 245.79B | 201.54B | 220.94B | 241.28B | 210.1B | 206.56B | 201.08B | 184.99B | 178.56B |
Operating Income | 25.45B | 47.6B | 24.18B | 38.39B | 11.5B | -281.09B | -13.41B | -61.93B | -71.75B | -102.42B | 10.87B | -5.71B | 66.28B | 17.08B | 53.65B | 85.93B | 58.34B | 20.47B | 65.87B | 32.02B | 18.76B |
Interest Income | n/a | n/a | n/a | n/a | 40.16B | 38.46B | 7.57B | 18.03B | 39.17B | 15.9B | 8.84B | 29.84B | 61.91B | 32.67B | 14.95B | 8.72B | 3.09B | 15.49B | 2.68B | 1.42B | 4.78B |
Pretax Income | 5.82B | 18.02B | 70.61B | -68.02B | 37.48B | -302.84B | -56.16B | -53.93B | -49.86B | -94.54B | -32.01B | 13.12B | 113.66B | 41.6B | 62.76B | 90.09B | 56.69B | 44.3B | 54.66B | 24.97B | 13.87B |
Net Income | -4.52B | 10.01B | 35.11B | -30.91B | 24.38B | -202.06B | -33.43B | -43.19B | -33.15B | -53.32B | -20.75B | 11.07B | 69.99B | 28.47B | 44.78B | 53.23B | 35.66B | 24.11B | 22.47B | 5.1B | -6.76B |
Selling & General & Admin | 133.62B | 154.72B | 146.07B | 149.06B | 151.24B | 67.71B | 170.24B | 171.14B | 178.07B | 13.37B | 195.82B | 251.28B | 195.98B | 40.22B | 173.15B | 168.18B | 165.55B | 16.31B | 151.54B | 141.01B | 146.27B |
Research & Development | n/a | n/a | n/a | n/a | n/a | 44.56B | 44.1B | n/a | 45.5B | 50.28B | 47.5B | n/a | 46.3B | 47.22B | 40.9B | 42.8B | 41B | 49.75B | n/a | n/a | n/a |
Other Expenses | 4.63B | -14.62B | 17.35B | -9.1B | 9.1B | n/a | -43.92B | 17.95B | n/a | n/a | n/a | -14.22B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 138.25B | 140.09B | 163.42B | 139.95B | 160.34B | 112.27B | 170.42B | 189.09B | 188.84B | 215.44B | 183.23B | 237.06B | 192.18B | 193.32B | 173.37B | 167.85B | 166.5B | 195.56B | 136.26B | 143.31B | 146.5B |
Interest Expense | n/a | n/a | n/a | n/a | 14.18B | 13.11B | 36.77B | 10.03B | 17.29B | 8.02B | 51.72B | 11B | 14.53B | 8.15B | 5.84B | 4.56B | 4.74B | n/a | 14.25B | 8.46B | 9.67B |
Selling & Marketing Expenses | n/a | 104.69B | n/a | n/a | n/a | -299.95B | n/a | n/a | n/a | 150.03B | n/a | n/a | n/a | 119.14B | n/a | n/a | n/a | 100.85B | n/a | n/a | n/a |
Cost & Expenses | 500.69B | 653.85B | 639.25B | 590.86B | 600.64B | 921.12B | 633.58B | 685.66B | 622.85B | 721.1B | 700.5B | 760.14B | 720.52B | 719.23B | 665.09B | 612.8B | 595.38B | 633.37B | 531.02B | 504.9B | 468.12B |
Income Tax Expense | 1.94B | 16.03B | 9.63B | -13.85B | 3.6B | -2.34B | 1.74B | 1.93B | 1.32B | -5.98B | -642M | 25.17B | 28.55B | 10.82B | 14.9B | 21.16B | 17.81B | 30.35B | 15.96B | 11.5B | 11.92B |
Shares Outstanding (Basic) | 327.3M | 327.68M | 327.21M | 327.19M | 327.29M | 327.19M | 327.07M | 327.06M | 327.04M | 327.07M | 326.99M | 326.99M | 326.99M | 326.99M | 327M | 327M | 327M | 327M | 327M | 327M | 327M |
Shares Outstanding (Diluted) | 327.3M | 327.69M | 327.19M | 327.19M | 327.29M | 327.19M | 327.07M | 327.06M | 327.04M | 327.07M | 326.99M | 326.99M | 326.99M | 326.99M | 327M | 327M | 327M | 327M | 327M | 327M | 327M |
EPS (Basic) | -13.8 | 30.60 | 107.30 | -94.45 | 74.50 | -617.55 | -102.2 | -132.05 | -101.35 | -163.05 | -63.45 | 33.85 | 214.05 | 87.05 | 136.95 | 162.75 | 109.05 | 73.70 | 68.70 | 15.60 | -20.65 |
EPS (Diluted) | -13.8 | 30.55 | 107.30 | -94.45 | 74.50 | -617.55 | -102.2 | -132.05 | -101.35 | -163.05 | -63.45 | 33.85 | 214.05 | 87.05 | 136.95 | 162.75 | 109.05 | 73.70 | 68.70 | 15.60 | -20.65 |
EBITDA | 65B | 91.77B | 77.09B | 72.71B | 62.42B | -249.64B | 19.39B | -4.55B | -20.41B | -75.16B | 69.28B | 66.23B | 97.32B | 56.6B | 86.9B | 113.56B | 81.17B | 35.63B | 101.83B | 66.28B | 55.42B |
EBIT | 35.28B | 59.6B | 44.48B | 39.46B | 28.85B | -289.73B | -13.59B | -43.91B | -32.58B | -86.52B | 19.71B | 24.12B | 128.19B | 49.75B | 68.6B | 94.65B | 61.44B | 31.46B | 68.27B | 33.14B | 23.25B |
Depreciation & Amortization | 29.72B | 32.17B | 32.62B | 33.24B | 33.57B | 40.09B | 38.78B | 39.35B | 39.3B | 40.84B | 41.3B | 42.11B | 43.71B | 39.65B | 39.32B | 40.13B | 37.57B | 38B | 33.56B | 33.15B | 32.18B |